The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients

Nephron

Volumn 84, Issue 3, 2000, Pages 211-217

  Roxborough, Heather E ^a,c   Mercer, Caroline ^a   McMaster, Dorothy ^a   Maxwell, A Peter ^b   Young, Ian S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Caeruloplasmin; Copper; Erroxidase activity; Haemodialysis

Indexed keywords

ANTIOXIDANT; CERULOPLASMIN; FERROUS ION; FREE RADICAL; TRANSFERRIN;

ADULT; AGED; ARTICLE; BODY FLUID; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEVICE; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0034012366     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045579     Document Type: Article

References (21)

1. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic haemodialysis. Nephron 1982;31:103-110.
2. Raine AEG, MacMahon SH, Selwood NH, Wing AJ, Brunner FP: Mortality from myocardial infarction in patients on renal replacement therapy in the UK. Nephrol Dial Transplant 1991;6:902.
3. Witztum JL: Role of oxidized low density lipoprotein in atherogenesis. Br Heart J 1993;69: S12-S18.
4. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJ: Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Periton Dial Int 1992;12:252-256.
5. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 1994; 87:679-683.
6. Peuchant E, Carbonneau M-A, Dubourg L, Thomas M-J, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status. Free Radic Biol Med 1994;16:339-346.
7. Gutteridge JM: Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities. Chem Biol Interact 1985;56:113-120.
8. Samokyszyn VM, Miller DM, Reif DW, Aust SD: Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem 1989;264:21-26.
9. Gutteridge JMC, Rowley DA, Halliwell B: Superoxide-dependent formation of hydroxyl radicals in the presence of irons salts. Biochem J 1981;199:263-265.
10. Johnson DA, Osaki S, Frieden E: A micro-method for the determination of ferroxidase (caeruloplasmin) in human serum. Clin Chem 1967;13:142-150.
11. Gutteridge JMC, Winyard PG, Blake DR, Lunec J, Brailsford S, Halliwell B: The behaviour of caeruloplasmin in stored human extracellular fluids in relation in ferroxidase II activity, lipid-peroxidation and phenathroline-detectable copper. Biochem J 1985;230:517-523.
12. Delorgeril M, Richard MJ, Arnaud J, Boissonat P, Guidollet J, Dureau G, Renaud S, Favier A: Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis. Am Heart J 1993;125: 974-980.
13. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftachi H, Laporte F, Foret M, Favier A, Cordonnier D: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-15.
14. Sondheimer JH, Mahajan SK, Rye DL, Abuhamdan DK, Migdal SD, Prasad AS, McDonald FD: Elevated plasma copper in chronic renal failure. Am J Clin Nutr 1988;47:896-899.
15. Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, Suchanek M: Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 1998;16:253-260.
16. Halliwell B: Free radicals, reactive oxygen species and human disease: A critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989;70:737-757.
17. Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS: Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron 1999;81:278-283.
18. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR: Detection of oxidants in uremic patients by electron spin resonance spectroscopy. Kidney Int 1995;48:199-206.
19. Islam KN, Takahashi M, Higashiyama S, Myint T, Uozumi N, Kayanoki Y, Kaneto H, Kosaka H, Taniguchi N: Fragmentation of ceruloplasmin following non-enzymatic glycation reaction. J Biochem 1995;118:1054-1060.
20. Vlassara H: Serum advanced glycosylation end products: A new class of uremic toxins. Blood Purif 1994;12:54-59.
21. Roxborough HE, Millar CA, McEneny J, Young IS: Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Biochem Biophys Res Commun 1995;214:1073-1078.